Department of Orthopaedic Surgery, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Department of Orthopaedic Surgery, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Yatap-dong, Bundang-gu, Seongnam, 463-712, Gyeonggi-do, Korea.
Knee Surg Sports Traumatol Arthrosc. 2022 Nov;30(11):3851-3861. doi: 10.1007/s00167-022-06975-8. Epub 2022 May 6.
Patch augmentation for large and massive rotator cuff tears (LMRCTs) has been suggested as a repair strategy that can mechanically reinforce tendons and biologically enhance healing potential. The purpose of this study was to determine whether patients who underwent patch augmentation would have lower rates of retears and superior functional outcomes.
Patients who underwent arthroscopic rotator cuff repair (ARCR) with patch augmentation (group A) were matched by age, sex, degree of retraction, and supraspinatus muscle occupation ratio to those treated with ARCR without using a patch (group B) with a minimum follow-up of 24 months. The retear (Sugaya IV or V) rates were evaluated by magnetic resonance imaging at 3 and 12 months post-surgery. The Constant- Murley Score (CMS), Korean Shoulder Score (KSS), and University of California-Los Angeles Shoulder Rating Scale (UCLA) score were retrospectively analyzed.
This study included 34 patients (group A, n = 17; group B, n = 17). The mean follow-up period was 46.5 ± 17.4 months. At postoperative 1-year follow-up, group B (6 patients, 35.3%) showed higher rates of retears than group A (1 patient, 5.9%), which was statistically significant (P = 0.034). However, the postoperative CMS, KSS, and UCLA scores did not differ between the two groups at 3 months, 12 months, and the final follow-up. Additionally, the clinical outcomes of patients with retear were not significantly different from those of the healed patients in both groups.
The use of an allodermal patch for LMRCT is effective in preventing retears without complications. However, the clinical outcomes of ARCR using allodermal patch augmentation were not superior to those of only ARCR.
III.
对于大型和巨大肩袖撕裂(LMRCT),已经提出了补片增强修复策略,该策略可以机械地增强肌腱,并在生物学上增强愈合潜力。本研究的目的是确定接受补片增强修复的患者的再撕裂率是否较低,且功能结果更好。
对接受关节镜下肩袖修复(ARCR)加补片(A 组)和仅接受 ARCR 不加补片(B 组)的患者进行了回顾性研究,两组患者均接受了至少 24 个月的随访。术后 3 个月和 12 个月通过磁共振成像(MRI)评估再撕裂(Sugaya Ⅳ或 V 级)的发生率。回顾性分析 Constant-Murley 评分(CMS)、韩国肩肘评分(KSS)和加利福尼亚大学洛杉矶分校(UCLA)评分。
本研究共纳入 34 例患者(A 组 17 例,B 组 17 例)。平均随访时间为 46.5±17.4 个月。术后 1 年随访时,B 组(6 例,35.3%)的再撕裂率高于 A 组(1 例,5.9%),差异具有统计学意义(P=0.034)。然而,两组患者在术后 3 个月、12 个月和最终随访时的 CMS、KSS 和 UCLA 评分无显著差异。此外,两组中再撕裂患者的临床结果与愈合患者无显著差异。
对于 LMRCT,使用同种异体真皮补片是一种有效的预防再撕裂的方法,且无并发症。然而,与仅接受 ARCR 相比,使用同种异体真皮补片增强修复 ARCR 的临床效果并没有优势。
III 级。